Answers are grounded in this paper and cite their sources.
This review aims to summarize the application of human induced pluripotent stem cell-derived systems for investigating misfolded protein aggregation and intercellular propagation in neurodegenerative disease. Traditional animal models have limited ability to recapitulate the genetic complexity, cellular heterogeneity, and human-specific vulnerabilities of the brain. Human induced pluripotent stem cell-based platforms offer a human-relevant experimental system to explore pathological protein initiation, seeded amplification, and cell-to-cell spread. We discuss progress in modelling these processes using induced pluripotent stem cell-derived neural cultures and brain organoids, together with the cellular mechanisms underlying propagation, such as extracellular vesicles, tunneling nanotubes and neuroimmune signaling. We also describe the use of these models in target identification, drug screening and regenerative research, and address major constraints including epigenetic rejuvenation, incomplete cellular maturation and inter-model variability. Emerging strategies to improve the physiological fidelity of induced pluripotent stem cell models are further considered.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: